News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Slideshows|May 30, 2019

6 news stories you can't afford to miss

Author(s)Miranda Hester

Here are the 6 news stories from the past week that you can't afford to miss.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Younger children face higher risk after water bead ingestion

Younger children face higher risk after water bead ingestion

ByMorgan Ebert, Executive Editor

July 31st 2026

Parenting role models shape mothers' COVID-19 vaccination intent | Image Credit: © Studio Romantic - stock.adobe.com

Parenting role models shape mothers' COVID-19 vaccination intent

ByContemporary Pediatrics Staff

July 31st 2026

CTx-1301 improves pediatric ADHD symptoms in phase 3 trial | Image Credit: © Tiara - stock.adobe.com.

CTx-1301 improves pediatric ADHD symptoms in phase 3 trial

ByContemporary Pediatrics Staff

July 30th 2026

Family history alone may not prompt type 1 diabetes screening, survey finds | Image Credit: © Africa Studio - stock.adobe.com

Family history alone may not prompt type 1 diabetes screening, survey finds

ByMorgan Ebert, Executive Editor

July 30th 2026

E-bike injuries surge among children as experts urge pediatric counseling on safe riding

E-bike injuries surge among children as experts urge pediatric counseling on safe riding

ByJohn Austin, MD

July 29th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Family history alone may not prompt type 1 diabetes screening, survey finds

Ensitrelvir now available in US for COVID-19 postexposure prophylaxis

Parenting role models shape mothers' COVID-19 vaccination intent

Omalizumab outperforms multiallergen oral immunotherapy in multifood allergy trial

FDA approves centanafadine for ADHD in children, adolescents, and adults